All In Biotech

Free tool

FAERS Monitor: Loratadine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021734 or its brand name (Loratadine, Loratadine). Reports on generic versions are filed under their own applications.

Reports

49,834

Serious

29,895

60% of reports

Hospitalization

14,104

Death reported

2,936

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,709
  • fatigue3,379
  • nausea2,814
  • dyspnoea2,540
  • headache2,517
  • diarrhoea2,470
  • off label use2,351
  • dizziness2,167
  • pain2,046
  • rash1,681
  • pruritus1,604
  • cough1,584
  • pneumonia1,572
  • vomiting1,540
  • arthralgia1,489

Reports by year received

View as table
YearReports
2004356
2005531
2006420
2007362
2008435
2009581
2010700
2011926
20121,188
20131,219
20141,408
20152,714
20163,655
20173,345
20183,624
20194,225
20203,755
20213,484
20223,782
20233,354
20243,615
20253,565
20262,590

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,004,325 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
coughSignal1,5842.42.31,291
pneumoniaSignal1,5722.12.0859
dyspnoea2,5401.91.81,103
dizziness2,1671.81.8843
fatigue3,3791.81.81,328
pruritus1,6041.81.7538
headache2,5171.71.6739
rash1,6811.61.6416
diarrhoea2,4701.61.6598
arthralgia1,4891.51.4263
nausea2,8141.51.4489
pain2,0461.41.3247
vomiting1,5401.41.3167
drug ineffective3,7091.21.2118
off label use2,3511.11.138

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.